Use of double cells to power an implantable medical device
    1.
    发明公开
    Use of double cells to power an implantable medical device 审中-公开
    Vorrichtung Verrichtung冯多佩尔泽伦zur Energieversorgung植物学家medizinischer Vorrichtung

    公开(公告)号:EP0930665A2

    公开(公告)日:1999-07-21

    申请号:EP98309397.2

    申请日:1998-11-17

    IPC分类号: H01M6/50 H01M6/46 H01M6/16

    摘要: A power source including two alkali metal/transition metal oxide cells discharged in parallel to power an implantable medical device is described. The first cell powers the medical device in both a device monitoring mode, for example in a cardiac defibrillator for monitoring the heart beat, and a device actuation mode for charging capacitors requiring high rate electrical pulse discharging. At such time as the first cell is discharged to a predetermined voltage limit, the first cell is disconnected from pulse discharge duty and only used for the device monitoring function. At that time, the second cell is utilized for the high rate electrical pulse discharging function. When the first cell reaches 100% efficiency or a present voltage limit, the second cell then takes over both device monitoring and device actuation functions. In that manner, a greater average discharge efficiency is realized from the two cells than is capable of being delivered from a single cell of similar chemistry.

    摘要翻译: 描述了包括并联排放的两个碱金属/过渡金属氧化物电池以为可植入医疗装置供电的电源。 第一单元在设备监视模式中为医疗设备供电,例如用于监测心跳的心脏除颤器,以及用于对需要高速率电脉冲放电的电容器进行充电的器件致动模式。 在第一电池放电到预定电压极限的时候,第一电池与脉冲放电占空比断开,仅用于器件监视功能。 此时,第二个电池用于高速电脉冲放电功能。 当第一个电池达到100%效率或当前的电压限制时,第二个电池接管器件监测和器件致动功能。 以这种方式,从两个电池实现的平均放电效率比能够从类似化学的单个电池输送的平均放电效率更高。

    Use of double cells to power an implantable medical device
    2.
    发明公开
    Use of double cells to power an implantable medical device 审中-公开
    使用双电池供应能量,植入式医疗设备

    公开(公告)号:EP0930665A3

    公开(公告)日:2002-08-21

    申请号:EP98309397.2

    申请日:1998-11-17

    摘要: A power source including two alkali metal/transition metal oxide cells discharged in parallel to power an implantable medical device is described. The first cell powers the medical device in both a device monitoring mode, for example in a cardiac defibrillator for monitoring the heart beat, and a device actuation mode for charging capacitors requiring high rate electrical pulse discharging. At such time as the first cell is discharged to a predetermined voltage limit, the first cell is disconnected from pulse discharge duty and only used for the device monitoring function. At that time, the second cell is utilized for the high rate electrical pulse discharging function. When the first cell reaches 100% efficiency or a present voltage limit, the second cell then takes over both device monitoring and device actuation functions. In that manner, a greater average discharge efficiency is realized from the two cells than is capable of being delivered from a single cell of similar chemistry.